Dekker Mark J, Gusba Jenny E, Robinson Lindsay E, Graham Terry E
Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada N1G 2W1.
Br J Nutr. 2007 Sep;98(3):556-62. doi: 10.1017/S0007114507730738. Epub 2007 May 25.
Acute caffeine ingestion increases serum NEFA and plasma adrenaline and decreases insulin sensitivity. Although frequently suggested, it is not known if a tolerance to these alterations in glucose homeostasis is developed in habitual caffeine consumers. Our objective was to determine whether acute caffeine ingestion continued to alter insulin, glucose, NEFA and adrenaline during an oral glucose tolerance test (OGTT) following 14 d of caffeine consumption. Twelve caffeine-naive young males underwent four OGTTs over a 4-week period. Subjects ingested a gelatin-filled placebo (PLA) capsule on the first trial day and 5 mg caffeine/kg body weight on the remaining three trial days (day 0, day 7, day 14) before a 2 h OGTT. Following day 0 and day 7, subjects were given six dosages of 5 mg caffeine/kg to consume per d between trials. Serum insulin and blood glucose area under the curve (AUC) were significantly elevated (P < 0.05) v. PLA on day 0 (36 and 103 %, respectively) and were not different from PLA on day 7. On day 14, insulin AUC was 29 % greater than PLA (P < 0.05), and glucose was greater (P < 0.05) during the first hour, although the 50 % elevation in glucose AUC was not different from PLA. Before the OGTT, caffeine resulted in greater (P < 0.05) serum NEFA and plasma adrenaline concentrations in all three caffeine trials, but both NEFA and adrenaline concentrations were decreased (P < 0.05) on day 14 v. day 0. Although 14 d of caffeine consumption by previously caffeine-naive subjects reduced its impact on glucose homeostasis, carbohydrate metabolism remained disrupted.
急性摄入咖啡因会增加血清非酯化脂肪酸(NEFA)和血浆肾上腺素水平,并降低胰岛素敏感性。尽管经常有人提出,但尚不清楚习惯性咖啡因消费者是否会对这些葡萄糖稳态变化产生耐受性。我们的目的是确定在摄入咖啡因14天后进行口服葡萄糖耐量试验(OGTT)期间,急性摄入咖啡因是否会继续改变胰岛素、葡萄糖、NEFA和肾上腺素水平。12名未接触过咖啡因的年轻男性在4周内进行了4次OGTT。在第一次试验日,受试者服用了明胶填充的安慰剂(PLA)胶囊,在其余三个试验日(第0天、第7天、第14天),在进行2小时OGTT之前,受试者服用5毫克/千克体重的咖啡因。在第0天和第7天之后,受试者在试验期间每天服用6次剂量为5毫克/千克的咖啡因。与PLA相比,第0天血清胰岛素和血糖曲线下面积(AUC)显著升高(P<0.05)(分别升高36%和103%),第7天与PLA无差异。在第14天,胰岛素AUC比PLA高29%(P<0.05),尽管葡萄糖AUC升高50%与PLA无差异,但在第一个小时内葡萄糖水平更高(P<0.05)。在OGTT之前,在所有三次咖啡因试验中,咖啡因导致血清NEFA和血浆肾上腺素浓度更高(P<0.05),但与第0天相比,第14天NEFA和肾上腺素浓度均降低(P<0.05)。尽管之前未接触过咖啡因的受试者摄入14天咖啡因后,其对葡萄糖稳态的影响有所降低,但碳水化合物代谢仍受到干扰。